H.R. 2427 · 108th Congress
Imports of Prescription Drugs bill
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
53 cosponsors · 17 D, 35 R, 1 I
26 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Jun 11, 2003
- House Passed Jul 25, 2003 243–186
Pharmaceutical Market Access Act of 2003 - (Sec. 4) Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products).
What it does: CRS summary · Passed House without amendment · Jul 25, 2003
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)
Pharmaceutical Market Access Act of 2003 - (Sec. 4) Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products).
Amends provision pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product.
Amends provisions regarding the importation of covered products, including to remove language directing the Secretary to require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received.
Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests).
Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products.
(Sec. 5) Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Pharmaceutical Market Access Act of 2003
Latest action (Jul 25, 2003): Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: House · Introduced: Jun 11, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Jun 11, 2003
- House Passed Jul 25, 2003 243–186
Final vote · House · Jul 25, 2003
Passage — Passed. Vote details
Speaker of the House: J. Dennis Hastert